Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Belgian Proposal On Single-Use Device Reuse Puts Onus On Manufacturers

This article was originally published in The Gray Sheet

Executive Summary

The U.S. should formally object to a proposal by the government of Belgium that places on manufacturers the burden of demonstrating that an approved device for single-use only cannot be reprocessed and resold, the Medical Device Manufacturing Association maintains.
Advertisement

Related Content

Canada Examining Single-Use Device Reuse Activity, International Regs
Canada Examining Single-Use Device Reuse Activity, International Regs
Belgian Reuse Proposal Exceeds EU Medical Device Directive - DG III Official
Belgian Reuse Proposal Exceeds EU Medical Device Directive - DG III Official
HIMA Targets French Market While Local European Budgets Cap Technology
HIMA Targets French Market While Local European Budgets Cap Technology
BVMed Targets Hospitals, Media In Campaign On Reuse Of Single-Use Devices
Advertisement
UsernamePublicRestriction

Register

MT012254

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel